Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Non-Current Deffered Revenue (2017 - 2025)

Historic Non-Current Deffered Revenue for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to $1.7 million.

  • Assembly Biosciences' Non-Current Deffered Revenue fell 9472.49% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 9472.49%. This contributed to the annual value of $35.4 million for FY2024, which is 3611.66% down from last year.
  • Assembly Biosciences' Non-Current Deffered Revenue amounted to $1.7 million in Q3 2025, which was down 9472.49% from $13.0 million recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Non-Current Deffered Revenue ranged from a high of $55.4 million in Q4 2023 and a low of $1.7 million during Q3 2025
  • In the last 5 years, Assembly Biosciences' Non-Current Deffered Revenue had a median value of $2.7 million in 2021 and averaged $15.3 million.
  • As far as peak fluctuations go, Assembly Biosciences' Non-Current Deffered Revenue surged by 192630.81% in 2023, and later plummeted by 9472.49% in 2025.
  • Over the past 5 years, Assembly Biosciences' Non-Current Deffered Revenue (Quarter) stood at $2.7 million in 2021, then changed by 0.0% to $2.7 million in 2022, then skyrocketed by 1926.31% to $55.4 million in 2023, then plummeted by 36.12% to $35.4 million in 2024, then tumbled by 95.15% to $1.7 million in 2025.
  • Its Non-Current Deffered Revenue was $1.7 million in Q3 2025, compared to $13.0 million in Q2 2025 and $22.8 million in Q1 2025.